Aqdot and Elementis to collaborate

Matt Dixon • Feb 10, 2021

Aqdot and Elementis establish exclusive agreement to deliver proven odour capture and fragrance release benefits to anti-perspirant and deodorant formulators.

About Elementis

Elementis is a global specialty chemical company listed on the London Stock Exchange. The company is known for its expertise in rheology and natural, sustainable ingredients and focuses on scientific innovation and development of products that enhance the performance and value of customers' products in the personal care, and coating markets. Our personal care products, including our market-leading anti-perspirant actives, touch consumers every day with ingredients providing protection, moisturization, and elegant sensorial experiences.

About Aqdot

Headquartered in Cambridge, England, Aqdot® is a supramolecular chemtech company with a focus on improving air quality through licensing and selling its AqFresh™ platform technology. AqFresh™ is a novel and versatile performance chemistry that has exceptional capability at capturing, holding and releasing materials. Effective dry or when formulated in liquids and coatings, this powerful chemistry is game-changing in a wide range of industries.


AqFresh™ has no hazard warning for human health or the environment and has achieved a Platinum Material Health Certificate (MHC) from the Cradle to Cradle Products Innovation Institute. AqFresh™ is a trademark of Aqdot Limited.

CCD Partners' role

CCD Partners' Peter Dixon and Matt Dixon advised Elementis on market innovators and introduced Aqdot to Elementis. 

Tim Wright, CEO of Aqdot, commented:

“We are delighted to partner with Elementis in the anti-perspirant and deodorant product category given their strength in the global market. We are confident that Elementis’ expertise and go-to-market capabilities will rapidly create significant value for their customers and consumers around the world with AqFresh." 


Stijn Dejonckheere, SVP of Elementis, commented:

“We are looking forward to bringing this much needed solution to the global anti-perspirant and deodorant market while also complementing our market-leading portfolio of actives and ingredients for anti-perspirant and deodorant applications.”


Joe Lupia, SVP of Elementis, commented:

“Elementis operates in multiple overlapping markets where innovation is a strong driver of growth. CCD Partners has given us insight and fore-warning in adjacent markets where we had less visibility and has played a key role in us developing strategic partnerships with potentially disruptive innovators, strengthening our competitive position." 


CCD Partners is a consultancy specialised in corporate transformations in small and mid-market chemicals and life sciences businesses.

To organise a call with one of our partners please email contact@ccdpartners.com

Receive M&A news relevant to your business

At critical moments our clients engage us to provide pre-publicity "off-market" intelligence to give them the edge over the competition - we also provide up-to-the-minute public or "on-market" intelligence for free

Contact Us

We're committed to your privacy. CCD Partners uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe at any time. For more information, please see our Privacy Policy.   

RECENT POSTS

By Matt Dixon 05 Dec, 2022
Market leading provider of formulated chemical process aids and foam control, PennWhite has been acquired by Manali Petrochemicals, part of the AM International Holdings group.
By Matt Dixon 02 Dec, 2022
Global source of industrial gas news, views, and debate, gas world has been sold by John and Karen Raquet to the senior management team in an MBO, backed by Mobeus Equity Partners.
By Matt Dixon 13 Sep, 2022
Polyblend UK Ltd is one of the market leaders in PVC based polymers. We are experts in manufacturing a comprehensive range of liquid plastisol and dispersion systems, complemented by our Speciality Distribution business supplying plasticisers, resins and PVC additives.
By Matt Dixon 05 May, 2022
GFBiochemicals is a sustainable chemicals company that produces levulinic acid derivatives at commercial scale directly from biomass. Having perfected its technology, product, and certification, the company is entering a new phase of commercialization.
By CCD Partners 20 Apr, 2022
In the latest episode of the Chemical Transformations podcast , CCD Partners' Managing Partner Matt Dixon speaks with Ted Clark, former President and CEO of Royal Adhesives & Sealants, discussing his new book "Shipping Clerk to CEO: The Power of Curiosity, Will, and Self Directed Learning”. The book tells the story of Clark’s remarkable career journey from entry-level worker to CEO of a $240m chemical company by the age of 42.
By Matt Dixon 04 Feb, 2022
Esteve Química purchases one of the UQUIFA Group's two pharmaceutical fine chemicals plants in Barcelona.
By Matt Dixon 04 Feb, 2022
Specialty materials manufacturer Vertellus has acquired Polyscope Polymers B.V., a global leader in specialty additives for coatings, electronics applications, and engineering polymers.
By Matt Dixon 01 Nov, 2021
Biosynth Carbosynth is a fully hybrid Research Products, Life Sciences Reagents and Custom Synthesis and Manufacturing Services Company with global research, manufacturing and distribution facilities. They are the supplier of choice for many in the pharmaceutical, life science, food, agrochemical, cosmetic and diagnostic sectors and manufacture and source a vast range of chemical and biochemical products.
By CCD Partners 12 Oct, 2021
Steve Allin co-founded Charnwood Molecular with Phil Page in 1998. 22 years later, the business has evolved dramatically from its origins as a spinout of Loughborough University. Backed by a partnership with Synova Capital, the company is now preparing to move into a former AstraZeneca research facility and has already completed its first M&A deal, acquiring Aurelia Bioscience in summer 2021. CCD Partners’ Matt Dixon spoke with Steve about the journey from full-time academia to running a high-growth market leader.
By Matt Dixon 24 Sep, 2021
Aspire was founded in 2009. Aspire has an asset-light business model that focuses on R&D, business development and sales and marketing, while outsourcing manufacturing and distribution to specialist third parties. For more details see www.aspirepharma.co.uk.
Show More
Share by: